GE Dehumidifier Recall Expanded Following More Fire Reports

More than 350,000 dehumidifiers have been added to a prior recall first issued last year, after the manufacturer and federal safety regulators continued to receive reports that the products are catching fire or overheating during use, posing a serious risk of fires and burns for consumers.  

A GE dehumidifier recall expansion was announced by the U.S. Consumer Product Safety Commission (CPSC) on January 30, after at least 16 additional consumer complaints were received involving overheating dehumidifiers.

Among the complaints were at least five reports of the units sparking fires, which caused more than $430,000 in property damage. No injuries have been reported, but the products could cause a serious risk of burns for individuals who come into contact with the dehumidifiers.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

An original recall of 2.2 million GE dehumidifiers was announced by the CPSC on September 13, 2013, after over 100 customers complaints of the units overheating or bursting into flames, causing $2.1 million worth of property damage. Multiple brands were included in the September recall, but additional GE brands are being added following new reports of problems.

The dehumidifier recall now includes 30, 40, 50, and 65-pint dehumidifiers with the GE brand name. The dehumidifiers measure between 19 and 23 inches tall by 13 to 15 inches wide by 9 and 11 inches in depth and were manufactured in a light gray plastic.

All affected models have a nameplate sticker on the back of the dehumidifier where the brand name, model number, pint capacity, and manufacture date can be located. A full list of recalled dehumidifiers has been posted on the CPSC recall webpage.

The affected units were manufactured in China under Gree Electric Appliances where they were imported by GE Appliances of Louisville, Kentucky and sold at Sam’s Club, Walmart, and other stores nationwide and in Canada. The units were also sold online at and from April 2008 through December 2011 for between $180 and $270.

Including this recall expansion, there has been a total of 71 fires and an estimated $2,725,000.00 worth of property damage caused by Gree manufactured dehumidifiers.

The CPSC recommends that customers stop using the dehumidifiers immediately, unplug them, and contact Gree at 866-853-2802, or visit them online at and navigate to the “Recall” link for instructions on how to receive and full refund.

Image Credit: |


Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Leadership Development Committee for Suboxone Dental Injury Lawyers Established in Federal MDL
Leadership Development Committee for Suboxone Dental Injury Lawyers Established in Federal MDL (Posted yesterday)

The U.S. District Judge presiding over all Suboxone lawsuits has created a mentorship program to use the litigation to provide some attorneys an opportunity to gain experience in handling complex federal multidistrict litigations.

Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M
Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M (Posted 3 days ago)

Gilead says it will pay $40 million to resolve HIV drug lawsuits over Truvada, Atripla, Viread, Stribild and Complera pending in the federal court system, involving claims that the the company sat on safer formulations of the drugs for years to increase profits.